"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","31/51","481/2914",7.09876665832243e-13,3.04537089642032e-10,1.77842785755867e-10,"ABL1/AKT1/AKT2/AKT3/BRCA1/CASP6/ERBB2/FOS/MAPK1/MAPK3/MDM2/MYC/PPP2CA/SIRT1/SP1/TP53/AR/CTNNB1/DAXX/FBXW7/HDAC4/SMAD4/UBE2I/JUN/BCL6/VDR/TCF7L2/GATA2/RUNX2/E2F4/SREBF1",31
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","31/51","499/2914",1.99312926934817e-12,4.27526228275182e-10,2.49665666370981e-10,"ABL1/AKT1/AKT2/AKT3/BRCA1/CASP6/ERBB2/FOS/MAPK1/MAPK3/MDM2/MYC/PPP2CA/SIRT1/SP1/TP53/AR/CTNNB1/DAXX/FBXW7/HDAC4/SMAD4/UBE2I/JUN/BCL6/VDR/TCF7L2/GATA2/RUNX2/E2F4/SREBF1",31
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","11/51","62/2914",3.98819712907697e-09,5.70312189458006e-07,3.33049444463269e-07,"ABL1/AKT1/AKT2/AKT3/MAPK1/MAPK3/AR/FBXW7/HDAC4/SMAD4/RUNX2",11
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","7/51","24/2914",9.0877022442016e-08,7.79724852552497e-06,4.55341712446312e-06,"ABL1/MAPK1/MAPK3/AR/HDAC4/SMAD4/RUNX2",7
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","7/51","24/2914",9.0877022442016e-08,7.79724852552497e-06,4.55341712446312e-06,"AKT1/AKT2/AKT3/FOS/MAPK1/MAPK3/ELK1",7
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","7/51","29/2914",3.83345671125394e-07,2.34936132732563e-05,1.37197398086983e-05,"AKT1/AKT2/AKT3/MDM2/PPP2CA/TP53/DAXX",7
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","7/51","29/2914",3.83345671125394e-07,2.34936132732563e-05,1.37197398086983e-05,"AKT1/AKT2/AKT3/MDM2/PPP2CA/TP53/DAXX",7
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","7/51","30/2914",4.93381526878225e-07,2.64575843788448e-05,1.54506320259234e-05,"FOS/MAPK1/MAPK3/PPP2CA/RPS6KA5/ELK1/JUN",7
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","11/51","108/2914",1.49399481304915e-06,7.12137527553427e-05,4.15872240357541e-05,"AKT1/AKT2/AKT3/FOS/MAPK1/MAPK3/MYC/SP1/HSPB1/ELK1/JUN",11
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","12/51","136/2914",2.18719489359231e-06,9.38306609351099e-05,5.4794987860523e-05,"AKT1/AKT2/AKT3/FOS/MAPK1/MAPK3/MYC/SP1/HSPB1/ELK1/JUN/SREBF1",12
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","8/51","63/2914",9.29786708847701e-06,0.000362616816450603,0.000211760035125122,"AKT1/AKT2/AKT3/FOS/MAPK1/MAPK3/HSPB1/ELK1",8
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","5/51","19/2914",1.30022850892015e-05,0.000454999180544936,0.000265709250324365,"ABL1/MAPK1/MAPK3/AR/RUNX2",5
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","7/51","49/2914",1.61488854300671e-05,0.000454999180544936,0.000265709250324365,"AKT1/AKT2/AKT3/SIRT1/SMAD4/BCL6/SREBF1",7
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","4/51","10/2914",1.61907574744693e-05,0.000454999180544936,0.000265709250324365,"FOS/MAPK1/MAPK3/JUN",4
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","4/51","10/2914",1.61907574744693e-05,0.000454999180544936,0.000265709250324365,"AKT1/AKT2/AKT3/TP53",4
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","13/51","194/2914",1.69696664072703e-05,0.000454999180544936,0.000265709250324365,"AKT1/AKT2/AKT3/BRCA1/CASP6/FOS/MDM2/PPP2CA/TP53/DAXX/JUN/BCL6/E2F4",13
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","5/51","21/2914",2.21591045572446e-05,0.000559191520885762,0.000326555225054132,"MAPK1/MAPK3/PPP2CA/RPS6KA5/ELK1",5
"R-HSA-1358803","R-HSA-1358803","Downregulation of ERBB2:ERBB3 signaling","4/51","11/2914",2.51143991157573e-05,0.000598559845592215,0.000349545437985394,"AKT1/AKT2/AKT3/ERBB2",4
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","7/51","53/2914",2.74682679975925e-05,0.000620204577419325,0.00036218547276604,"MDM2/MYC/TP53/CTNNB1/HDAC4/SMAD4/TCF7L2",7
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","15/51","268/2914",2.93699137473566e-05,0.000629984649880799,0.000367896814308993,"AKT1/AKT2/AKT3/ERBB2/JAK2/MAPK1/MAPK3/MDM2/MYC/PPP2CA/CTNNB1/FBXW7/HDAC4/SMAD4/TCF7L2",15
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","5/51","23/2914",3.56843931238817e-05,0.000728981173816441,0.000425708549548063,"MAPK1/MAPK3/MDM2/SP1/TP53",5
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","8/51","77/2914",4.19080720537715e-05,0.000817207405048544,0.000477230676975962,"ABL1/AKT1/AKT2/AKT3/JAK2/MYC/PPP2CA/E2F4",8
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","5/51","24/2914",4.44821163005942e-05,0.00082968816925891,0.000484519161535077,"MAPK1/MAPK3/PPP2CA/RPS6KA5/ELK1",5
"R-HSA-198323","R-HSA-198323","AKT phosphorylates targets in the cytosol","4/51","13/2914",5.30202193596248e-05,0.000891407595153368,0.000520561913008224,"AKT1/AKT2/AKT3/MDM2",4
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","5/51","25/2914",5.48713445557791e-05,0.000891407595153368,0.000520561913008224,"AKT1/AKT2/AKT3/TRIB3/CTNNB1",5
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","14/51","249/2914",5.5693936008834e-05,0.000891407595153368,0.000520561913008224,"ABL1/AKT1/AKT2/AKT3/BRCA1/JAK2/MAPK1/MAPK3/MDM2/MYC/PPP2CA/TP53/UBE2I/E2F4",14
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","7/51","59/2914",5.61025759187435e-05,0.000891407595153368,0.000520561913008224,"AKT1/AKT2/AKT3/MAPK1/MAPK3/TP53/JUN",7
"R-HSA-450294","R-HSA-450294","MAP kinase activation","7/51","60/2914",6.2667954695235e-05,0.000960162591580566,0.000560713278852103,"FOS/MAPK1/MAPK3/PPP2CA/RPS6KA5/ELK1/JUN",7
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","4/51","14/2914",7.32715246257564e-05,0.00108391324360171,0.000632980866095464,"AKT1/AKT2/AKT3/TP53",4
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","6/51","44/2914",9.04657202922294e-05,0.00129365980017888,0.000755468120335108,"FOS/MAPK1/MAPK3/MDM2/TP53/JUN",6
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","7/51","64/2914",9.55464372126123e-05,0.00132223940529712,0.000772157964570517,"FOS/MAPK1/MAPK3/PPP2CA/RPS6KA5/ELK1/JUN",7
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","11/51","172/2914",0.000132169870223241,0.00177190232268032,0.00103475095766879,"AKT1/AKT2/AKT3/ERBB2/MAPK1/MAPK3/MDM2/PPP2CA/TP53/TRIB3/JUN",11
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","5/51","31/2914",0.000162084911342448,0.00210710384745183,0.00123050108132385,"AKT1/AKT2/CTNNB1/TCF7L2/SOX6",5
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","6/51","49/2914",0.000167636288496612,0.00211517552250137,0.00123521475734346,"AKT1/AKT2/AKT3/MAPK1/MAPK3/TP53",6
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","8/51","95/2914",0.000190313510728006,0.00233269988863756,0.00136224407678994,"AKT1/AKT2/AKT3/BRCA1/MDM2/PPP2CA/TP53/DAXX",8
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","8/51","99/2914",0.000254079979388226,0.00294595435560943,0.00172037084194589,"AKT1/AKT2/AKT3/ERBB2/MAPK1/MAPK3/PPP2CA/TRIB3",8
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","8/51","99/2914",0.000254079979388226,0.00294595435560943,0.00172037084194589,"FOS/MAPK1/MAPK3/MDM2/SP1/TP53/CEBPB/JUN",8
"R-HSA-389513","R-HSA-389513","CTLA4 inhibitory signaling","4/51","19/2914",0.000265911659746503,0.00300200268503289,0.00175310180109883,"AKT1/AKT2/AKT3/PPP2CA",4
"R-HSA-109581","R-HSA-109581","Apoptosis","8/51","101/2914",0.000292007757810084,0.00321208533591092,0.00187578532682321,"AKT1/AKT2/AKT3/CASP6/MAPK1/MAPK3/TP53/CTNNB1",8
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","8/51","103/2914",0.000334465677037884,0.00328450540248802,0.00191807701089964,"AKT1/AKT2/AKT3/CASP6/MAPK1/MAPK3/TP53/CTNNB1",8
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","11/51","191/2914",0.000336765470114264,0.00328450540248802,0.00191807701089964,"ABL1/AKT1/AKT2/AKT3/JAK2/MAPK1/MAPK3/MYC/PPP2CA/TP53/E2F4",11
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","7/51","78/2914",0.000336872348973131,0.00328450540248802,0.00191807701089964,"FOS/MAPK1/MAPK3/PPP2CA/RPS6KA5/ELK1/JUN",7
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","7/51","78/2914",0.000336872348973131,0.00328450540248802,0.00191807701089964,"FOS/MAPK1/MAPK3/PPP2CA/RPS6KA5/ELK1/JUN",7
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","7/51","78/2914",0.000336872348973131,0.00328450540248802,0.00191807701089964,"FOS/MAPK1/MAPK3/PPP2CA/RPS6KA5/ELK1/JUN",7
"R-HSA-389357","R-HSA-389357","CD28 dependent PI3K/Akt signaling","4/51","21/2914",0.000400101552237971,0.00381430146466866,0.00222746595164063,"AKT1/AKT2/AKT3/TRIB3",4
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","8/51","107/2914",0.000434606121774363,0.00405317448350438,0.00236696240234092,"BRCA1/MDM2/TP53/AR/DAXX/HDAC4/UBE2I/VDR",8
"R-HSA-2990846","R-HSA-2990846","SUMOylation","8/51","109/2914",0.000493162212963033,0.00431377629012172,0.00251914797460181,"BRCA1/MDM2/TP53/AR/DAXX/HDAC4/UBE2I/VDR",8
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","5/51","39/2914",0.000494107817655073,0.00431377629012172,0.00251914797460181,"AKT1/AKT2/AKT3/MYC/E2F4",5
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","7/51","83/2914",0.000495115420340242,0.00431377629012172,0.00251914797460181,"FOS/MAPK1/MAPK3/PPP2CA/RPS6KA5/ELK1/JUN",7
"R-HSA-69206","R-HSA-69206","G1/S Transition","6/51","60/2914",0.000518191766101197,0.00431377629012172,0.00251914797460181,"AKT1/AKT2/AKT3/MYC/PPP2CA/E2F4",6
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","11/51","201/2914",0.000525035230823646,0.00431377629012172,0.00251914797460181,"AKT1/AKT2/AKT3/ERBB2/MAPK1/MAPK3/MDM2/PPP2CA/TP53/TRIB3/JUN",11
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","7/51","84/2914",0.000532937397147905,0.00431377629012172,0.00251914797460181,"FOS/MAPK1/MAPK3/PPP2CA/RPS6KA5/ELK1/JUN",7
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","7/51","84/2914",0.000532937397147905,0.00431377629012172,0.00251914797460181,"FOS/MAPK1/MAPK3/PPP2CA/RPS6KA5/ELK1/JUN",7
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","5/51","40/2914",0.000557281788301556,0.00442729420706236,0.00258543987555108,"AKT1/AKT2/AKT3/MYC/E2F4",5
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","4/51","23/2914",0.000576837961291452,0.00449933609807332,0.00262751071363379,"DUSP1/JAK2/MAPK1/MAPK3",4
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","7/51","86/2914",0.000615507962575785,0.00455263648181055,0.00265863693453787,"FOS/MAPK1/MAPK3/PPP2CA/RPS6KA5/ELK1/JUN",7
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","7/51","86/2914",0.000615507962575785,0.00455263648181055,0.00265863693453787,"FOS/MAPK1/MAPK3/PPP2CA/RPS6KA5/ELK1/JUN",7
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","7/51","86/2914",0.000615507962575785,0.00455263648181055,0.00265863693453787,"FOS/MAPK1/MAPK3/PPP2CA/RPS6KA5/ELK1/JUN",7
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","7/51","87/2914",0.000660455505979194,0.00458030651397263,0.00267479560869951,"FOS/MAPK1/MAPK3/PPP2CA/RPS6KA5/ELK1/JUN",7
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","7/51","87/2914",0.000660455505979194,0.00458030651397263,0.00267479560869951,"FOS/MAPK1/MAPK3/PPP2CA/RPS6KA5/ELK1/JUN",7
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","7/51","87/2914",0.000660455505979194,0.00458030651397263,0.00267479560869951,"FOS/MAPK1/MAPK3/PPP2CA/RPS6KA5/ELK1/JUN",7
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","4/51","24/2914",0.000683309130289623,0.00458030651397263,0.00267479560869951,"MYC/SP1/SMAD4/E2F4",4
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","4/51","24/2914",0.000683309130289623,0.00458030651397263,0.00267479560869951,"AKT1/AKT2/AKT3/MDM2",4
"R-HSA-8863795","R-HSA-8863795","Downregulation of ERBB2 signaling","4/51","24/2914",0.000683309130289623,0.00458030651397263,0.00267479560869951,"AKT1/AKT2/AKT3/ERBB2",4
"R-HSA-210745","R-HSA-210745","Regulation of gene expression in beta cells","3/51","11/2914",0.000755179830893631,0.0049086689008086,0.00286655183018635,"AKT1/AKT2/AKT3",3
"R-HSA-9614399","R-HSA-9614399","Regulation of localization of FOXO transcription factors","3/51","11/2914",0.000755179830893631,0.0049086689008086,0.00286655183018635,"AKT1/AKT2/AKT3",3
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","7/51","90/2914",0.000811190077295919,0.00511765504646984,0.00298859502161654,"FOS/MAPK1/MAPK3/PPP2CA/RPS6KA5/ELK1/JUN",7
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","7/51","90/2914",0.000811190077295919,0.00511765504646984,0.00298859502161654,"FOS/MAPK1/MAPK3/PPP2CA/RPS6KA5/ELK1/JUN",7
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","8/51","119/2914",0.000890344483876667,0.00553562005192884,0.00323267714969713,"PTGS2/SP1/TRIB3/ARNTL/UBE2I/VDR/CLOCK/SREBF1",8
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","5/51","45/2914",0.000968606662750022,0.00593617511885371,0.00346659226668429,"FOS/MAPK1/MAPK3/CEBPB/JUN",5
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","3/51","12/2914",0.00099451119014565,0.00600908874045752,0.00350917217575485,"MAPK1/MAPK3/PPP2CA",3
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","7/51","94/2914",0.00105333290939211,0.00627610858512797,0.0036651057373585,"AKT1/FOS/JAK2/MYC/PTGS2/TP53/BCL6",7
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","10/51","187/2914",0.00117599768343979,0.00686639516190291,0.00400981977311469,"FOS/MAPK1/MAPK3/MDM2/SIRT1/SP1/TP53/AR/CEBPB/JUN",10
"R-HSA-1989781","R-HSA-1989781","PPARA activates gene expression","5/51","47/2914",0.00118441315147043,0.00686639516190291,0.00400981977311469,"SP1/TRIB3/ARNTL/CLOCK/SREBF1",5
"R-HSA-4090294","R-HSA-4090294","SUMOylation of intracellular receptors","4/51","28/2914",0.00125030858814748,0.00702327164759803,0.00410143209944382,"AR/HDAC4/UBE2I/VDR",4
"R-HSA-8957322","R-HSA-8957322","Metabolism of steroids","4/51","28/2914",0.00125030858814748,0.00702327164759803,0.00410143209944382,"SP1/UBE2I/VDR/SREBF1",4
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","10/51","189/2914",0.00127692527668155,0.00702327164759803,0.00410143209944382,"FOS/MAPK1/MAPK3/MDM2/SIRT1/SP1/TP53/AR/CEBPB/JUN",10
"R-HSA-8876198","R-HSA-8876198","RAB GEFs exchange GTP for GDP on RABs","3/51","13/2914",0.00127695848138146,0.00702327164759803,0.00410143209944382,"AKT1/AKT2/AKT3",3
"R-HSA-400206","R-HSA-400206","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)","5/51","48/2914",0.00130479993529605,0.00708555914230389,0.0041378065902793,"SP1/TRIB3/ARNTL/CLOCK/SREBF1",5
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","4/51","29/2914",0.00143174630396412,0.00767773955500758,0.00448362658346658,"AKT1/AKT2/AKT3/TP53",4
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","3/51","14/2914",0.00160523674231483,0.00850180941300077,0.00496486477804977,"MAPK1/MAPK3/PPP2CA",3
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","4/51","30/2914",0.00163082225233288,0.00853198471037569,0.00498248647054206,"FOS/MAPK1/MAPK3/JUN",4
"R-HSA-389356","R-HSA-389356","CD28 co-stimulation","4/51","31/2914",0.00184841296951665,0.00955384534846559,0.00557923001578901,"AKT1/AKT2/AKT3/TRIB3",4
"R-HSA-400253","R-HSA-400253","Circadian Clock","5/51","52/2914",0.00187863889208659,0.00959447719887078,0.00560295809920561,"SIRT1/ARNTL/BHLHE40/CLOCK/SREBF1",5
"R-HSA-111447","R-HSA-111447","Activation of BAD and translocation to mitochondria ","3/51","15/2914",0.00198188888031907,0.0100027097606692,0.00584135669988779,"AKT1/AKT2/AKT3",3
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","5/51","53/2914",0.00204715344150195,0.0102119630977248,0.00596355592506075,"AKT1/AKT2/AKT3/PPP2CA/TRIB3",5
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","4/51","32/2914",0.00208538964921449,0.0102831282702645,0.00600511477934723,"MAPK1/MAPK3/TP53/JUN",4
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","15/51","397/2914",0.00234161373310276,0.0112346317777236,0.00656077134854182,"ABL1/AKT1/AKT2/AKT3/ERBB2/MAPK1/MAPK3/MYC/CTNNB1/RPS6KA5/SMAD4/CEBPB/JUN/GATA2/SREBF1",15
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","7/51","108/2914",0.00237840173228624,0.0112346317777236,0.00656077134854182,"AKT1/AKT2/MYC/PPP2CA/CTNNB1/TCF7L2/SOX6",7
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","6/51","80/2914",0.00238192484688467,0.0112346317777236,0.00656077134854182,"KEAP1/MDM2/MYC/TP53/AR/SMAD4",6
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","3/51","16/2914",0.00240929166328805,0.0112346317777236,0.00656077134854182,"MDM2/TP53/UBE2I",3
"R-HSA-392451","R-HSA-392451","G beta:gamma signalling through PI3Kgamma","3/51","16/2914",0.00240929166328805,0.0112346317777236,0.00656077134854182,"AKT1/AKT2/AKT3",3
"R-HSA-1643685","R-HSA-1643685","Disease","16/51","443/2914",0.00257820253510629,0.0116871499210335,0.00682503172912763,"AKT1/AKT2/AKT3/ERBB2/JAK2/MAPK1/MAPK3/MDM2/MYC/PPP2CA/CTNNB1/FBXW7/HDAC4/SMAD4/JUN/TCF7L2",16
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","4/51","34/2914",0.00262095052393351,0.0116871499210335,0.00682503172912763,"DUSP1/MAPK1/MAPK3/PPP2CA",4
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","4/51","34/2914",0.00262095052393351,0.0116871499210335,0.00682503172912763,"ABL1/BRCA1/TP53/UBE2I",4
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","4/51","34/2914",0.00262095052393351,0.0116871499210335,0.00682503172912763,"BRCA1/FOS/TP53/JUN",4
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","7/51","110/2914",0.00264254904974416,0.0116871499210335,0.00682503172912763,"FOS/MAPK1/MAPK3/PPP2CA/RPS6KA5/ELK1/JUN",7
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","4/51","35/2914",0.00292123802799658,0.0126586981213185,0.00739239394644535,"AKT1/AKT2/AKT3/TP53",4
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","4/51","35/2914",0.00292123802799658,0.0126586981213185,0.00739239394644535,"ABL1/BRCA1/TP53/UBE2I",4
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","6/51","85/2914",0.00324313902706861,0.0137803111316212,0.00804739062526281,"AKT1/AKT2/AKT3/TRIB3/CTNNB1/HSPB1",6
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","4/51","36/2914",0.0032443156743444,0.0137803111316212,0.00804739062526281,"MYC/SP1/SMAD4/E2F4",4
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","13/51","332/2914",0.00361777696646178,0.0152159443001187,0.00888576798780086,"AKT1/FOS/JAK2/MAPK1/MAPK3/MYC/PPP2CA/PTGS2/TP53/RPS6KA5/ELK1/JUN/BCL6",13
"R-HSA-1368108","R-HSA-1368108","BMAL1:CLOCK,NPAS2 activates circadian gene expression","3/51","19/2914",0.00401740071716314,0.0167326690064368,0.00977150097787254,"ARNTL/BHLHE40/CLOCK",3
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","4/51","40/2914",0.00478082762726729,0.0194940472243091,0.0113840835219864,"ABL1/JAK2/PPP2CA/E2F4",4
"R-HSA-69236","R-HSA-69236","G1 Phase","4/51","40/2914",0.00478082762726729,0.0194940472243091,0.0113840835219864,"ABL1/JAK2/PPP2CA/E2F4",4
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","6/51","92/2914",0.00481671096917662,0.0194940472243091,0.0113840835219864,"AKT1/AKT2/AKT3/TRIB3/CTNNB1/HSPB1",6
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","7/51","124/2914",0.00518131739061393,0.0207736930894708,0.0121313678206209,"BRCA1/KEAP1/MDM2/MYC/TP53/AR/SMAD4",7
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","13/51","347/2914",0.00532459899441728,0.0211504904500464,0.0123514089734046,"AKT1/AKT2/AKT3/ERBB2/JAK2/MAPK1/MAPK3/PPP2CA/TRIB3/CTNNB1/HSPB1/RPS6KA5/ELK1",13
"R-HSA-397795","R-HSA-397795","G-protein beta:gamma signalling","3/51","21/2914",0.00537984324714235,0.0211738784681107,0.012365067047995,"AKT1/AKT2/AKT3",3
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","7/51","127/2914",0.00590810689260058,0.0230416168811422,0.0134557841190329,"FOS/MAPK1/MAPK3/PPP2CA/RPS6KA5/ELK1/JUN",7
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","3/51","22/2914",0.00615307255501816,0.023780793928854,0.013887446828775,"MYC/CTNNB1/TCF7L2",3
"R-HSA-1227986","R-HSA-1227986","Signaling by ERBB2","4/51","44/2914",0.00674546404972989,0.025837536404769,0.0150885380059748,"AKT1/AKT2/AKT3/ERBB2",4
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","5/51","70/2914",0.00690228420680964,0.0262042471214277,0.0153026887864061,"MAPK1/MAPK3/PPP2CA/RPS6KA5/ELK1",5
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","9/51","202/2914",0.00730421833711656,0.0273374217700485,0.0159644372010098,"DUSP1/ERBB2/JAK2/MAPK1/MAPK3/MYC/PPP2CA/HSPB1/JUN",9
"R-HSA-69242","R-HSA-69242","S Phase","5/51","71/2914",0.00732821329500135,0.0273374217700485,0.0159644372010098,"AKT1/AKT2/AKT3/MYC/E2F4",5
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","3/51","24/2914",0.00789039326033253,0.0289314419545526,0.0168953090054804,"AKT1/AKT2/AKT3",3
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","3/51","24/2914",0.00789039326033253,0.0289314419545526,0.0168953090054804,"JAK2/MAPK1/MAPK3",3
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","6/51","104/2914",0.00873607003570086,0.0311441847362341,0.0181875008397098,"AKT1/MYC/TP53/FBXW7/HDAC4/JUN",6
"R-HSA-5663213","R-HSA-5663213","RHO GTPases Activate WASPs and WAVEs","3/51","25/2914",0.00885685440051412,0.0311441847362341,0.0181875008397098,"ABL1/MAPK1/MAPK3",3
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","3/51","25/2914",0.00885685440051412,0.0311441847362341,0.0181875008397098,"ERBB2/MYC/UBE2I",3
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","3/51","25/2914",0.00885685440051412,0.0311441847362341,0.0181875008397098,"AKT1/AKT2/AKT3",3
"R-HSA-9007101","R-HSA-9007101","Rab regulation of trafficking","3/51","25/2914",0.00885685440051412,0.0311441847362341,0.0181875008397098,"AKT1/AKT2/AKT3",3
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","4/51","49/2914",0.00987360784465745,0.034437217604537,0.020110557698147,"FOS/MYC/SP1/JUN",4
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","3/51","27/2914",0.0109904359662506,0.037719176236172,0.0220271474523591,"MAPK1/MAPK3/PPP2CA",3
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","3/51","27/2914",0.0109904359662506,0.037719176236172,0.0220271474523591,"MYC/CEBPB/GATA2",3
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","4/51","52/2914",0.0121400993266987,0.0398560751464074,0.0232750481777572,"AKT2/MAPK1/MAPK3/TRIB3",4
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","4/51","52/2914",0.0121400993266987,0.0398560751464074,0.0232750481777572,"AKT2/MAPK1/MAPK3/TRIB3",4
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","3/51","28/2914",0.012159251251623,0.0398560751464074,0.0232750481777572,"MAPK1/MAPK3/PPP2CA",3
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","2/51","10/2914",0.012356312341427,0.0398560751464074,0.0232750481777572,"JAK2/MAPK3",2
"R-HSA-111458","R-HSA-111458","Formation of apoptosome","2/51","10/2914",0.012356312341427,0.0398560751464074,0.0232750481777572,"MAPK1/MAPK3",2
"R-HSA-1221632","R-HSA-1221632","Meiotic synapsis","2/51","10/2914",0.012356312341427,0.0398560751464074,0.0232750481777572,"BRCA1/UBE2I",2
"R-HSA-74749","R-HSA-74749","Signal attenuation","2/51","10/2914",0.012356312341427,0.0398560751464074,0.0232750481777572,"MAPK1/MAPK3",2
"R-HSA-9627069","R-HSA-9627069","Regulation of the apoptosome activity","2/51","10/2914",0.012356312341427,0.0398560751464074,0.0232750481777572,"MAPK1/MAPK3",2
"R-HSA-5633008","R-HSA-5633008","TP53 Regulates Transcription of Cell Death Genes","3/51","30/2914",0.0147043978431243,0.0464806797129016,0.0271436677013142,"CASP6/TP53/BCL6",3
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","3/51","30/2914",0.0147043978431243,0.0464806797129016,0.0271436677013142,"MAPK1/MAPK3/PPP2CA",3
"R-HSA-1362277","R-HSA-1362277","Transcription of E2F targets under negative control by DREAM complex","2/51","11/2914",0.0149343417882122,0.0464806797129016,0.0271436677013142,"MYC/E2F4",2
"R-HSA-6803207","R-HSA-6803207","TP53 Regulates Transcription of Caspase Activators and Caspases","2/51","11/2914",0.0149343417882122,0.0464806797129016,0.0271436677013142,"CASP6/TP53",2
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","8/51","188/2914",0.0149518270405138,0.0464806797129016,0.0271436677013142,"AKT2/DUSP1/ERBB2/JAK2/MAPK1/MAPK3/PPP2CA/TRIB3",8
"R-HSA-450531","R-HSA-450531","Regulation of mRNA stability by proteins that bind AU-rich elements","3/51","31/2914",0.0160818247938679,0.0492793059754953,0.028778002262711,"AKT1/ELAVL1/HSPB1",3
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","3/51","31/2914",0.0160818247938679,0.0492793059754953,0.028778002262711,"PPP2CA/CTNNB1/TCF7L2",3
"R-HSA-3371453","R-HSA-3371453","Regulation of HSF1-mediated heat shock response","3/51","32/2914",0.0175297318777976,0.0520744526880627,0.0304103048454396,"MAPK1/MAPK3/SIRT1",3
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","3/51","32/2914",0.0175297318777976,0.0520744526880627,0.0304103048454396,"MAPK1/MAPK3/RPS6KA5",3
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","3/51","32/2914",0.0175297318777976,0.0520744526880627,0.0304103048454396,"MAPK1/MAPK3/PPP2CA",3
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","2/51","12/2914",0.0177223079078255,0.0520744526880627,0.0304103048454396,"MAPK1/MAPK3",2
"R-HSA-170968","R-HSA-170968","Frs2-mediated activation","2/51","12/2914",0.0177223079078255,0.0520744526880627,0.0304103048454396,"MAPK1/MAPK3",2
"R-HSA-381771","R-HSA-381771","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","2/51","12/2914",0.0177223079078255,0.0520744526880627,0.0304103048454396,"CTNNB1/TCF7L2",2
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","5/51","89/2914",0.0184482644214695,0.053838812495309,0.0314406511443591,"MAPK1/MAPK3/PPP2CA/RPS6KA5/ELK1",5
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","3/51","33/2914",0.0190484433932662,0.0552147447007513,0.0322441644921576,"MAPK1/MAPK3/PPP2CA",3
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","3/51","34/2914",0.0206382007677177,0.0588450817729787,0.0343641993914095,"MYC/HSPB1/JUN",3
"R-HSA-169893","R-HSA-169893","Prolonged ERK activation events","2/51","13/2914",0.0207123714399063,0.0588450817729787,0.0343641993914095,"MAPK1/MAPK3",2
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","2/51","13/2914",0.0207123714399063,0.0588450817729787,0.0343641993914095,"MDM2/TP53",2
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","5/51","92/2914",0.0210153468263183,0.0593130512400693,0.0346374829962863,"AKT1/ERBB2/MAPK1/MAPK3/PPP2CA",5
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","4/51","62/2914",0.0220129707689246,0.0617226435285534,0.036044630498824,"ABL1/JAK2/TP53/GATA2",4
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","4/51","63/2914",0.0232073963967443,0.0632825152999851,0.0369555604009237,"MYC/SP1/SMAD4/E2F4",4
"R-HSA-2426168","R-HSA-2426168","Activation of gene expression by SREBF (SREBP)","2/51","14/2914",0.0238968938895049,0.0632825152999851,0.0369555604009237,"SP1/SREBF1",2
"R-HSA-400508","R-HSA-400508","Incretin synthesis, secretion, and inactivation","2/51","14/2914",0.0238968938895049,0.0632825152999851,0.0369555604009237,"CTNNB1/TCF7L2",2
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","2/51","14/2914",0.0238968938895049,0.0632825152999851,0.0369555604009237,"PPP2CA/CTNNB1",2
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","2/51","14/2914",0.0238968938895049,0.0632825152999851,0.0369555604009237,"PPP2CA/CTNNB1",2
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","2/51","14/2914",0.0238968938895049,0.0632825152999851,0.0369555604009237,"PPP2CA/CTNNB1",2
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","2/51","14/2914",0.0238968938895049,0.0632825152999851,0.0369555604009237,"PPP2CA/CTNNB1",2
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","2/51","14/2914",0.0238968938895049,0.0632825152999851,0.0369555604009237,"PPP2CA/CTNNB1",2
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","2/51","14/2914",0.0238968938895049,0.0632825152999851,0.0369555604009237,"PPP2CA/CTNNB1",2
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","6/51","130/2914",0.0243022867339212,0.0639612331831423,0.0373519163233661,"ABL1/MAPK1/MAPK3/PPP2CA/AR/CTNNB1",6
"R-HSA-1430728","R-HSA-1430728","Metabolism","10/51","289/2914",0.0253612990519023,0.066341446910159,0.038741907409196,"AKT1/PPP2CA/PTGS2/SP1/TRIB3/ARNTL/UBE2I/VDR/CLOCK/SREBF1",10
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","5/51","97/2914",0.0257972414052623,0.0663665346487749,0.0387565580822192,"AKT1/AKT2/AKT3/ERBB2/MDM2",5
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","3/51","37/2914",0.0258349913434625,0.0663665346487749,0.0387565580822192,"PPP2CA/CTNNB1/TCF7L2",3
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","3/51","37/2914",0.0258349913434625,0.0663665346487749,0.0387565580822192,"MAPK1/MAPK3/PPP2CA",3
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","2/51","15/2914",0.0272684331216873,0.0688126929953167,0.0401850593372233,"TP53/E2F4",2
"R-HSA-69541","R-HSA-69541","Stabilization of p53","2/51","15/2914",0.0272684331216873,0.0688126929953167,0.0401850593372233,"MDM2/TP53",2
"R-HSA-9604323","R-HSA-9604323","Negative regulation of NOTCH4 signaling","2/51","15/2914",0.0272684331216873,0.0688126929953167,0.0401850593372233,"AKT1/FBXW7",2
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","3/51","38/2914",0.0277098082107294,0.0695175890199,0.0405967027033154,"MAPK1/MAPK3/PPP2CA",3
"R-HSA-195721","R-HSA-195721","Signaling by WNT","7/51","172/2914",0.0282529873455709,0.0704682068095924,0.0411518420333284,"AKT1/AKT2/MYC/PPP2CA/CTNNB1/TCF7L2/SOX6",7
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","2/51","16/2914",0.0308197390443157,0.0755523888572083,0.044120889579231,"MAPK1/MAPK3",2
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","2/51","16/2914",0.0308197390443157,0.0755523888572083,0.044120889579231,"PPP2CA/CTNNB1",2
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","2/51","16/2914",0.0308197390443157,0.0755523888572083,0.044120889579231,"MAPK1/MAPK3",2
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","3/51","40/2914",0.0316726386334748,0.0772020566690949,0.045084258341908,"MYC/FBXW7/HDAC4",3
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","3/51","41/2914",0.0337602185121569,0.0818256143599734,0.047784311661572,"MAPK1/MAPK3/PPP2CA",3
"R-HSA-3232142","R-HSA-3232142","SUMOylation of ubiquitinylation proteins","2/51","17/2914",0.0345437493773522,0.0831274976582303,0.0485445821191481,"MDM2/UBE2I",2
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","12/51","393/2914",0.0346848999552989,0.0831274976582303,0.0485445821191481,"BRCA1/KEAP1/MDM2/MYC/TP53/AR/DAXX/FBXW7/HDAC4/SMAD4/UBE2I/VDR",12
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","3/51","42/2914",0.0359181873952895,0.0842016524184655,0.0491718642512447,"JAK2/MAPK1/MAPK3",3
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","3/51","42/2914",0.0359181873952895,0.0842016524184655,0.0491718642512447,"JAK2/MAPK1/MAPK3",3
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","3/51","42/2914",0.0359181873952895,0.0842016524184655,0.0491718642512447,"JAK2/MAPK1/MAPK3",3
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","3/51","42/2914",0.0359181873952895,0.0842016524184655,0.0491718642512447,"JAK2/MAPK1/MAPK3",3
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","3/51","43/2914",0.0381461850736546,0.0889386597641185,0.051938169608294,"ABL1/MAPK1/MAPK3",3
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","2/51","18/2914",0.0384335855070617,0.0891243685542134,0.0520466193495345,"MAPK1/MAPK3",2
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","2/51","19/2914",0.0424825484235203,0.097459964030429,0.0569144189406014,"MYC/E2F4",2
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","2/51","19/2914",0.0424825484235203,0.097459964030429,0.0569144189406014,"SMAD4/SREBF1",2
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","3/51","46/2914",0.0452459760316475,0.103247466582855,0.0602941897846142,"JAK2/MAPK1/MAPK3",3
"R-HSA-1655829","R-HSA-1655829","Regulation of cholesterol biosynthesis by SREBP (SREBF)","2/51","20/2914",0.0466841147398624,0.104855943578015,0.0612335040401612,"SP1/SREBF1",2
"R-HSA-437239","R-HSA-437239","Recycling pathway of L1","2/51","20/2914",0.0466841147398624,0.104855943578015,0.0612335040401612,"MAPK1/RPS6KA5",2
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","2/51","20/2914",0.0466841147398624,0.104855943578015,0.0612335040401612,"MAPK1/MAPK3",2
"R-HSA-111465","R-HSA-111465","Apoptotic cleavage of cellular proteins","2/51","21/2914",0.0510319327917277,0.114024474831517,0.0665877193225394,"CASP6/CTNNB1",2
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","4/51","81/2914",0.0515675305619208,0.114624200057327,0.0669379453162648,"ABL1/BRCA1/TP53/UBE2I",4
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","3/51","49/2914",0.0529582996477757,0.116508259225106,0.0680381933396524,"MAPK1/MAPK3/SIRT1",3
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","3/51","49/2914",0.0529582996477757,0.116508259225106,0.0680381933396524,"JAK2/MAPK1/MAPK3",3
"R-HSA-1500620","R-HSA-1500620","Meiosis","2/51","22/2914",0.0555198188153986,0.118801650147215,0.069377481867347,"BRCA1/UBE2I",2
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","2/51","22/2914",0.0555198188153986,0.118801650147215,0.069377481867347,"MAPK1/MAPK3",2
"R-HSA-525793","R-HSA-525793","Myogenesis","2/51","22/2914",0.0555198188153986,0.118801650147215,0.069377481867347,"ABL1/CTNNB1",2
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","2/51","22/2914",0.0555198188153986,0.118801650147215,0.069377481867347,"MDM2/TP53",2
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","2/51","22/2914",0.0555198188153986,0.118801650147215,0.069377481867347,"MDM2/TP53",2
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","3/51","50/2914",0.0556623116074366,0.118801650147215,0.069377481867347,"MAPK1/MAPK3/PPP2CA",3
"R-HSA-2644602","R-HSA-2644602","Signaling by NOTCH1 PEST Domain Mutants in Cancer","3/51","51/2914",0.0584317838193799,0.121685608051039,0.0710616481809526,"MYC/FBXW7/HDAC4",3
"R-HSA-2644603","R-HSA-2644603","Signaling by NOTCH1 in Cancer","3/51","51/2914",0.0584317838193799,0.121685608051039,0.0710616481809526,"MYC/FBXW7/HDAC4",3
"R-HSA-2644606","R-HSA-2644606","Constitutive Signaling by NOTCH1 PEST Domain Mutants","3/51","51/2914",0.0584317838193799,0.121685608051039,0.0710616481809526,"MYC/FBXW7/HDAC4",3
"R-HSA-2894858","R-HSA-2894858","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","3/51","51/2914",0.0584317838193799,0.121685608051039,0.0710616481809526,"MYC/FBXW7/HDAC4",3
"R-HSA-2894862","R-HSA-2894862","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","3/51","51/2914",0.0584317838193799,0.121685608051039,0.0710616481809526,"MYC/FBXW7/HDAC4",3
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","2/51","23/2914",0.0601417532031435,0.123448861838031,0.0720913485890111,"TP53/JUN",2
"R-HSA-4551638","R-HSA-4551638","SUMOylation of chromatin organization proteins","2/51","23/2914",0.0601417532031435,0.123448861838031,0.0720913485890111,"HDAC4/UBE2I",2
"R-HSA-5685938","R-HSA-5685938","HDR through Single Strand Annealing (SSA)","2/51","23/2914",0.0601417532031435,0.123448861838031,0.0720913485890111,"ABL1/BRCA1",2
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","4/51","86/2914",0.0617878805675553,0.126223813159434,0.0737118575191888,"MYC/SP1/SMAD4/E2F4",4
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","4/51","87/2914",0.0639531570569008,0.129841475718203,0.075824490788694,"FOS/MAPK1/MAPK3/JUN",4
"R-HSA-373760","R-HSA-373760","L1CAM interactions","3/51","53/2914",0.0641640859027016,0.129841475718203,0.075824490788694,"MAPK1/MAPK3/RPS6KA5",3
"R-HSA-1474165","R-HSA-1474165","Reproduction","2/51","24/2914",0.0648918768343082,0.130086986737936,0.0759678636820725,"BRCA1/UBE2I",2
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","2/51","24/2914",0.0648918768343082,0.130086986737936,0.0759678636820725,"MDM2/TP53",2
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","2/51","25/2914",0.069764487480725,0.139204488973168,0.0812922791697065,"MAPK1/MAPK3",2
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","3/51","55/2914",0.0701488480478371,0.139323406539454,0.0813617243439825,"MAPK1/MAPK3/PPP2CA",3
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","3/51","56/2914",0.0732337881744759,0.144780161874886,0.0845483462795308,"BRCA1/MDM2/TP53",3
"R-HSA-1445148","R-HSA-1445148","Translocation of SLC2A4 (GLUT4) to the plasma membrane","2/51","26/2914",0.0747540362850345,0.145770370755817,0.0851266059131014,"AKT1/AKT2",2
"R-HSA-75153","R-HSA-75153","Apoptotic execution phase","2/51","26/2914",0.0747540362850345,0.145770370755817,0.0851266059131014,"CASP6/CTNNB1",2
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","2/51","26/2914",0.0747540362850345,0.145770370755817,0.0851266059131014,"FBXW7/RUNX2",2
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","6/51","171/2914",0.0752972901115622,0.146165327863621,0.0853572519483296,"DUSP1/ERBB2/JAK2/MAPK1/MAPK3/PPP2CA",6
"R-HSA-165159","R-HSA-165159","mTOR signalling","2/51","27/2914",0.0798551243105372,0.153622638247625,0.0897121528718803,"AKT1/AKT2",2
"R-HSA-8939236","R-HSA-8939236","RUNX1 regulates transcription of genes involved in differentiation of HSCs","2/51","27/2914",0.0798551243105372,0.153622638247625,0.0897121528718803,"ABL1/GATA2",2
"R-HSA-5693567","R-HSA-5693567","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","3/51","59/2914",0.082848089790813,0.158668886251155,0.0926590477923567,"ABL1/BRCA1/UBE2I",3
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","6/51","177/2914",0.0858316581007132,0.16365236144536,0.0955692848092152,"DUSP1/ERBB2/JAK2/MAPK1/MAPK3/PPP2CA",6
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","2/51","29/2914",0.0903710516706435,0.170789344346723,0.0997371217139492,"TP53/JUN",2
"R-HSA-5673000","R-HSA-5673000","RAF activation","2/51","29/2914",0.0903710516706435,0.170789344346723,0.0997371217139492,"JAK2/PPP2CA",2
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","3/51","62/2914",0.0929817601552105,0.174952522397304,0.102168323716252,"ABL1/MAPK1/MAPK3",3
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","2/51","30/2914",0.0957758126583234,0.177869366365458,0.103871694749059,"TP53/FBXW7",2
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","2/51","30/2914",0.0957758126583234,0.177869366365458,0.103871694749059,"PPP2CA/CTNNB1",2
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","2/51","30/2914",0.0957758126583234,0.177869366365458,0.103871694749059,"TP53/E2F4",2
"R-HSA-5693538","R-HSA-5693538","Homology Directed Repair","3/51","63/2914",0.0964704783431339,0.178387220729329,0.104174110007558,"ABL1/BRCA1/UBE2I",3
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","3/51","64/2914",0.100012918189303,0.184143956666142,0.107535913842576,"MYC/FBXW7/HDAC4",3
"R-HSA-196854","R-HSA-196854","Metabolism of vitamins and cofactors","2/51","31/2914",0.101271949752424,0.184875176356552,0.107962929635283,"AKT1/PTGS2",2
"R-HSA-391251","R-HSA-391251","Protein folding","2/51","31/2914",0.101271949752424,0.184875176356552,0.107962929635283,"TP53/FBXW7",2
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","2/51","32/2914",0.106854764277399,0.194240228283916,0.113431908554955,"MAPK1/MAPK3",2
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","2/51","33/2914",0.112519688205407,0.203674878650294,0.118941531391903,"MAPK1/MAPK3",2
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","2/51","34/2914",0.118262281170263,0.213170246311104,0.124486611758172,"MAPK1/MAPK3",2
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","4/51","109/2914",0.121272307330656,0.217681254580968,0.127120938756644,"AKT1/ELAVL1/PPP2CA/HSPB1",4
"R-HSA-3899300","R-HSA-3899300","SUMOylation of transcription cofactors","2/51","37/2914",0.135913524550134,0.242945425133364,0.141874644047946,"DAXX/UBE2I",2
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","4/51","114/2914",0.136673562040842,0.243290282637018,0.142076033045296,"BRCA1/MDM2/PPP2CA/TP53",4
"R-HSA-3108214","R-HSA-3108214","SUMOylation of DNA damage response and repair proteins","2/51","38/2914",0.141924842124545,0.251594038311693,0.146925238911012,"BRCA1/UBE2I",2
"R-HSA-109582","R-HSA-109582","Hemostasis","8/51","298/2914",0.143762698692737,0.253803282877301,0.148215387866023,"ABL1/AKT1/JAK2/MAPK1/MAPK3/PPP2CA/TP53/GATA2",8
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","3/51","77/2914",0.150468836177849,0.264553814427447,0.154493455609698,"MAPK1/MAPK3/MDM2",3
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","2/51","40/2914",0.154115589068828,0.267674444172175,0.156315832935781,"CEBPB/SREBF1",2
"R-HSA-4086398","R-HSA-4086398","Ca2+ pathway","2/51","40/2914",0.154115589068828,0.267674444172175,0.156315832935781,"CTNNB1/TCF7L2",2
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","2/51","40/2914",0.154115589068828,0.267674444172175,0.156315832935781,"AKT1/FBXW7",2
"R-HSA-113501","R-HSA-113501","Inhibition of replication initiation of damaged DNA by RB1/E2F1","1/51","10/2914",0.162088262610712,0.275935970872997,0.161140378034041,"PPP2CA",1
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","1/51","10/2914",0.162088262610712,0.275935970872997,0.161140378034041,"E2F4",1
"R-HSA-4755510","R-HSA-4755510","SUMOylation of immune response proteins","1/51","10/2914",0.162088262610712,0.275935970872997,0.161140378034041,"UBE2I",1
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","1/51","10/2914",0.162088262610712,0.275935970872997,0.161140378034041,"JAK2",1
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","1/51","10/2914",0.162088262610712,0.275935970872997,0.161140378034041,"SIRT1",1
"R-HSA-109704","R-HSA-109704","PI3K Cascade","2/51","42/2914",0.16650613295171,0.2812249253397,0.164229008050174,"AKT2/TRIB3",2
"R-HSA-2980736","R-HSA-2980736","Peptide hormone metabolism","2/51","42/2914",0.16650613295171,0.2812249253397,0.164229008050174,"CTNNB1/TCF7L2",2
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","1/51","11/2914",0.176803654692961,0.285145743846919,0.166518677550157,"JAK2",1
"R-HSA-113510","R-HSA-113510","E2F mediated regulation of DNA replication","1/51","11/2914",0.176803654692961,0.285145743846919,0.166518677550157,"PPP2CA",1
"R-HSA-2586552","R-HSA-2586552","Signaling by Leptin","1/51","11/2914",0.176803654692961,0.285145743846919,0.166518677550157,"JAK2",1
"R-HSA-349425","R-HSA-349425","Autodegradation of the E3 ubiquitin ligase COP1","1/51","11/2914",0.176803654692961,0.285145743846919,0.166518677550157,"TP53",1
"R-HSA-380994","R-HSA-380994","ATF4 activates genes in response to endoplasmic reticulum  stress","1/51","11/2914",0.176803654692961,0.285145743846919,0.166518677550157,"CEBPB",1
"R-HSA-416572","R-HSA-416572","Sema4D induced cell migration and growth-cone collapse","1/51","11/2914",0.176803654692961,0.285145743846919,0.166518677550157,"ERBB2",1
"R-HSA-452723","R-HSA-452723","Transcriptional regulation of pluripotent stem cells","1/51","11/2914",0.176803654692961,0.285145743846919,0.166518677550157,"SMAD4",1
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","1/51","11/2914",0.176803654692961,0.285145743846919,0.166518677550157,"TP53",1
"R-HSA-8866910","R-HSA-8866910","TFAP2 (AP-2) family regulates transcription of growth factors and their receptors","1/51","11/2914",0.176803654692961,0.285145743846919,0.166518677550157,"ERBB2",1
"R-HSA-8978868","R-HSA-8978868","Fatty acid metabolism","1/51","11/2914",0.176803654692961,0.285145743846919,0.166518677550157,"PTGS2",1
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","1/51","11/2914",0.176803654692961,0.285145743846919,0.166518677550157,"JAK2",1
"R-HSA-9027276","R-HSA-9027276","Erythropoietin activates Phosphoinositide-3-kinase (PI3K)","1/51","11/2914",0.176803654692961,0.285145743846919,0.166518677550157,"JAK2",1
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","3/51","86/2914",0.189358753731496,0.300853986830202,0.175691936855817,"ABL1/GATA2/RUNX2",3
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","1/51","12/2914",0.191265595309792,0.300853986830202,0.175691936855817,"SMAD4",1
"R-HSA-2032785","R-HSA-2032785","YAP1- and WWTR1 (TAZ)-stimulated gene expression","1/51","12/2914",0.191265595309792,0.300853986830202,0.175691936855817,"RUNX2",1
"R-HSA-418990","R-HSA-418990","Adherens junctions interactions","1/51","12/2914",0.191265595309792,0.300853986830202,0.175691936855817,"CTNNB1",1
"R-HSA-112399","R-HSA-112399","IRS-mediated signalling","2/51","46/2914",0.191777240340956,0.300853986830202,0.175691936855817,"AKT2/TRIB3",2
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","2/51","46/2914",0.191777240340956,0.300853986830202,0.175691936855817,"AR/VDR",2
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","2/51","46/2914",0.191777240340956,0.300853986830202,0.175691936855817,"BRCA1/TP53",2
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","2/51","47/2914",0.198178474403996,0.300853986830202,0.175691936855817,"MAPK1/MAPK3",2
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","2/51","47/2914",0.198178474403996,0.300853986830202,0.175691936855817,"AKT1/ERBB2",2
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","2/51","47/2914",0.198178474403996,0.300853986830202,0.175691936855817,"AKT1/ERBB2",2
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","3/51","88/2914",0.198343844256792,0.300853986830202,0.175691936855817,"MAPK1/MAPK3/MDM2",3
"R-HSA-5693607","R-HSA-5693607","Processing of DNA double-strand break ends","2/51","48/2914",0.204607083666165,0.300853986830202,0.175691936855817,"BRCA1/UBE2I",2
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","6/51","228/2914",0.205204812913147,0.300853986830202,0.175691936855817,"ABL1/MAPK1/MAPK3/PPP2CA/AR/CTNNB1",6
"R-HSA-1368082","R-HSA-1368082","RORA activates gene expression","1/51","13/2914",0.205478363965616,0.300853986830202,0.175691936855817,"SREBF1",1
"R-HSA-4085377","R-HSA-4085377","SUMOylation of SUMOylation proteins","1/51","13/2914",0.205478363965616,0.300853986830202,0.175691936855817,"UBE2I",1
"R-HSA-4839735","R-HSA-4839735","AXIN mutants destabilize the destruction complex, activating WNT signaling","1/51","13/2914",0.205478363965616,0.300853986830202,0.175691936855817,"PPP2CA",1
"R-HSA-4839744","R-HSA-4839744","truncated APC mutants destabilize the destruction complex","1/51","13/2914",0.205478363965616,0.300853986830202,0.175691936855817,"PPP2CA",1
"R-HSA-4839748","R-HSA-4839748","AMER1 mutants destabilize the destruction complex","1/51","13/2914",0.205478363965616,0.300853986830202,0.175691936855817,"PPP2CA",1
"R-HSA-5467337","R-HSA-5467337","APC truncation mutants have impaired AXIN binding","1/51","13/2914",0.205478363965616,0.300853986830202,0.175691936855817,"PPP2CA",1
"R-HSA-5467340","R-HSA-5467340","AXIN missense mutants destabilize the destruction complex","1/51","13/2914",0.205478363965616,0.300853986830202,0.175691936855817,"PPP2CA",1
"R-HSA-5467348","R-HSA-5467348","Truncations of AMER1 destabilize the destruction complex","1/51","13/2914",0.205478363965616,0.300853986830202,0.175691936855817,"PPP2CA",1
"R-HSA-5626467","R-HSA-5626467","RHO GTPases activate IQGAPs","1/51","13/2914",0.205478363965616,0.300853986830202,0.175691936855817,"CTNNB1",1
"R-HSA-5689901","R-HSA-5689901","Metalloprotease DUBs","1/51","13/2914",0.205478363965616,0.300853986830202,0.175691936855817,"BRCA1",1
"R-HSA-6807505","R-HSA-6807505","RNA polymerase II transcribes snRNA genes","1/51","13/2914",0.205478363965616,0.300853986830202,0.175691936855817,"SP1",1
"R-HSA-8847993","R-HSA-8847993","ERBB2 Activates PTK6 Signaling","1/51","13/2914",0.205478363965616,0.300853986830202,0.175691936855817,"ERBB2",1
"R-HSA-912446","R-HSA-912446","Meiotic recombination","1/51","13/2914",0.205478363965616,0.300853986830202,0.175691936855817,"BRCA1",1
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","1/51","13/2914",0.205478363965616,0.300853986830202,0.175691936855817,"BCL6",1
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","2/51","49/2914",0.211060223411628,0.307975632121049,0.179850816942239,"MAPK1/MAPK3",2
"R-HSA-2428928","R-HSA-2428928","IRS-related events triggered by IGF1R","2/51","50/2914",0.217535136403469,0.308663628372986,0.1802525912226,"AKT2/TRIB3",2
"R-HSA-3214858","R-HSA-3214858","RMTs methylate histone arginines","1/51","14/2914",0.219446169356086,0.308663628372986,0.1802525912226,"JAK2",1
"R-HSA-381042","R-HSA-381042","PERK regulates gene expression","1/51","14/2914",0.219446169356086,0.308663628372986,0.1802525912226,"CEBPB",1
"R-HSA-450408","R-HSA-450408","AUF1 (hnRNP D0) binds and destabilizes mRNA","1/51","14/2914",0.219446169356086,0.308663628372986,0.1802525912226,"HSPB1",1
"R-HSA-5693554","R-HSA-5693554","Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)","1/51","14/2914",0.219446169356086,0.308663628372986,0.1802525912226,"BRCA1",1
"R-HSA-6785631","R-HSA-6785631","ERBB2 Regulates Cell Motility","1/51","14/2914",0.219446169356086,0.308663628372986,0.1802525912226,"ERBB2",1
"R-HSA-877312","R-HSA-877312","Regulation of IFNG signaling","1/51","14/2914",0.219446169356086,0.308663628372986,0.1802525912226,"JAK2",1
"R-HSA-9027284","R-HSA-9027284","Erythropoietin activates RAS","1/51","14/2914",0.219446169356086,0.308663628372986,0.1802525912226,"JAK2",1
"R-HSA-927802","R-HSA-927802","Nonsense-Mediated Decay (NMD)","1/51","14/2914",0.219446169356086,0.308663628372986,0.1802525912226,"PPP2CA",1
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","1/51","14/2914",0.219446169356086,0.308663628372986,0.1802525912226,"SMAD4",1
"R-HSA-975957","R-HSA-975957","Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)","1/51","14/2914",0.219446169356086,0.308663628372986,0.1802525912226,"PPP2CA",1
"R-HSA-2404192","R-HSA-2404192","Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)","2/51","51/2914",0.224029150794657,0.312040602892558,0.182224668110486,"AKT2/TRIB3",2
"R-HSA-2428924","R-HSA-2428924","IGF1R signaling cascade","2/51","51/2914",0.224029150794657,0.312040602892558,0.182224668110486,"AKT2/TRIB3",2
"R-HSA-8951664","R-HSA-8951664","Neddylation","2/51","51/2914",0.224029150794657,0.312040602892558,0.182224668110486,"KEAP1/FBXW7",2
"R-HSA-1170546","R-HSA-1170546","Prolactin receptor signaling","1/51","15/2914",0.233173150515685,0.31259775491009,0.182550032311622,"JAK2",1
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","1/51","15/2914",0.233173150515685,0.31259775491009,0.182550032311622,"SMAD4",1
"R-HSA-3371497","R-HSA-3371497","HSP90 chaperone cycle for steroid hormone receptors (SHR)","1/51","15/2914",0.233173150515685,0.31259775491009,0.182550032311622,"AR",1
"R-HSA-400685","R-HSA-400685","Sema4D in semaphorin signaling","1/51","15/2914",0.233173150515685,0.31259775491009,0.182550032311622,"ERBB2",1
"R-HSA-432142","R-HSA-432142","Platelet sensitization by LDL","1/51","15/2914",0.233173150515685,0.31259775491009,0.182550032311622,"PPP2CA",1
"R-HSA-5693537","R-HSA-5693537","Resolution of D-Loop Structures","1/51","15/2914",0.233173150515685,0.31259775491009,0.182550032311622,"BRCA1",1
"R-HSA-5693568","R-HSA-5693568","Resolution of D-loop Structures through Holliday Junction Intermediates","1/51","15/2914",0.233173150515685,0.31259775491009,0.182550032311622,"BRCA1",1
"R-HSA-6803204","R-HSA-6803204","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release","1/51","15/2914",0.233173150515685,0.31259775491009,0.182550032311622,"TP53",1
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","1/51","15/2914",0.233173150515685,0.31259775491009,0.182550032311622,"E2F4",1
"R-HSA-8862803","R-HSA-8862803","Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models","1/51","15/2914",0.233173150515685,0.31259775491009,0.182550032311622,"JUN",1
"R-HSA-8863678","R-HSA-8863678","Neurodegenerative Diseases","1/51","15/2914",0.233173150515685,0.31259775491009,0.182550032311622,"JUN",1
"R-HSA-8876384","R-HSA-8876384","Listeria monocytogenes entry into host cells","1/51","15/2914",0.233173150515685,0.31259775491009,0.182550032311622,"CTNNB1",1
"R-HSA-1963640","R-HSA-1963640","GRB2 events in ERBB2 signaling","1/51","16/2914",0.24666337794711,0.325595658890186,0.190140514822388,"ERBB2",1
"R-HSA-1963642","R-HSA-1963642","PI3K events in ERBB2 signaling","1/51","16/2914",0.24666337794711,0.325595658890186,0.190140514822388,"ERBB2",1
"R-HSA-6788467","R-HSA-6788467","IL-6-type cytokine receptor ligand interactions","1/51","16/2914",0.24666337794711,0.325595658890186,0.190140514822388,"JAK2",1
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","1/51","16/2914",0.24666337794711,0.325595658890186,0.190140514822388,"TP53",1
"R-HSA-8941858","R-HSA-8941858","Regulation of RUNX3 expression and activity","1/51","16/2914",0.24666337794711,0.325595658890186,0.190140514822388,"MDM2",1
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","7/51","296/2914",0.256413441805224,0.337427504706875,0.197050045688225,"AKT1/AKT2/AKT3/KEAP1/PPP2CA/TRIB3/FBXW7",7
"R-HSA-399719","R-HSA-399719","Trafficking of AMPA receptors","1/51","17/2914",0.25992085473272,0.337897111152536,0.197324285251634,"MDM2",1
"R-HSA-399721","R-HSA-399721","Glutamate binding, activation of AMPA receptors and synaptic plasticity","1/51","17/2914",0.25992085473272,0.337897111152536,0.197324285251634,"MDM2",1
"R-HSA-4570464","R-HSA-4570464","SUMOylation of RNA binding proteins","1/51","17/2914",0.25992085473272,0.337897111152536,0.197324285251634,"UBE2I",1
"R-HSA-5250941","R-HSA-5250941","Negative epigenetic regulation of rRNA expression","1/51","17/2914",0.25992085473272,0.337897111152536,0.197324285251634,"SIRT1",1
"R-HSA-69273","R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","1/51","18/2914",0.272949517628347,0.352696816453497,0.205966979060072,"PPP2CA",1
"R-HSA-8953750","R-HSA-8953750","Transcriptional Regulation by E2F6","1/51","18/2914",0.272949517628347,0.352696816453497,0.205966979060072,"BRCA1",1
"R-HSA-111885","R-HSA-111885","Opioid Signalling","2/51","59/2914",0.276374892965673,0.356050537784605,0.207925476610811,"MAPK1/PPP2CA",2
"R-HSA-112316","R-HSA-112316","Neuronal System","3/51","105/2914",0.278160098656415,0.356210992010752,0.2080191782568,"MAPK1/MAPK3/MDM2",3
"R-HSA-68886","R-HSA-68886","M Phase","3/51","105/2914",0.278160098656415,0.356210992010752,0.2080191782568,"MAPK1/MAPK3/PPP2CA",3
"R-HSA-421270","R-HSA-421270","Cell-cell junction organization","1/51","19/2914",0.285753238139726,0.363763024219414,0.212429394587709,"CTNNB1",1
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","1/51","19/2914",0.285753238139726,0.363763024219414,0.212429394587709,"RPS6KA5",1
"R-HSA-73894","R-HSA-73894","DNA Repair","4/51","157/2914",0.294212860984225,0.372052524176171,0.217270275435968,"ABL1/BRCA1/TP53/UBE2I",4
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","2/51","62/2914",0.296039398358421,0.372052524176171,0.217270275435968,"BRCA1/TP53",2
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","1/51","20/2914",0.298335823581825,0.372052524176171,0.217270275435968,"SMAD4",1
"R-HSA-70171","R-HSA-70171","Glycolysis","1/51","20/2914",0.298335823581825,0.372052524176171,0.217270275435968,"PPP2CA",1
"R-HSA-70326","R-HSA-70326","Glucose metabolism","1/51","20/2914",0.298335823581825,0.372052524176171,0.217270275435968,"PPP2CA",1
"R-HSA-73854","R-HSA-73854","RNA Polymerase I Promoter Clearance","1/51","20/2914",0.298335823581825,0.372052524176171,0.217270275435968,"MAPK3",1
"R-HSA-73864","R-HSA-73864","RNA Polymerase I Transcription","1/51","20/2914",0.298335823581825,0.372052524176171,0.217270275435968,"MAPK3",1
"R-HSA-4615885","R-HSA-4615885","SUMOylation of DNA replication proteins","1/51","21/2914",0.310701018121329,0.386349961663914,0.225619656179638,"UBE2I",1
"R-HSA-69275","R-HSA-69275","G2/M Transition","2/51","66/2914",0.322153323712027,0.39685880839914,0.231756585447173,"PPP2CA/TP53",2
"R-HSA-1250196","R-HSA-1250196","SHC1 events in ERBB2 signaling","1/51","22/2914",0.322852503802564,0.39685880839914,0.231756585447173,"ERBB2",1
"R-HSA-180024","R-HSA-180024","DARPP-32 events","1/51","22/2914",0.322852503802564,0.39685880839914,0.231756585447173,"PPP2CA",1
"R-HSA-9024446","R-HSA-9024446","NR1H2 and NR1H3-mediated signaling","1/51","22/2914",0.322852503802564,0.39685880839914,0.231756585447173,"SREBF1",1
"R-HSA-168249","R-HSA-168249","Innate Immune System","9/51","428/2914",0.329817268599492,0.404261737797664,0.236079729102795,"ABL1/FOS/MAPK1/MAPK3/PPP2CA/CTNNB1/RPS6KA5/ELK1/JUN",9
"R-HSA-201451","R-HSA-201451","Signaling by BMP","1/51","23/2914",0.334793901557083,0.404994417195346,0.236507597331597,"SMAD4",1
"R-HSA-5693616","R-HSA-5693616","Presynaptic phase of homologous DNA pairing and strand exchange","1/51","23/2914",0.334793901557083,0.404994417195346,0.236507597331597,"BRCA1",1
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","1/51","23/2914",0.334793901557083,0.404994417195346,0.236507597331597,"JAK2",1
"R-HSA-9020591","R-HSA-9020591","Interleukin-12 signaling","1/51","23/2914",0.334793901557083,0.404994417195346,0.236507597331597,"JAK2",1
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","2/51","68/2914",0.335135240336475,0.404994417195346,0.236507597331597,"PPP2CA/TP53",2
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","1/51","24/2914",0.346528772197204,0.412946786868335,0.241151601704487,"TP53",1
"R-HSA-5625740","R-HSA-5625740","RHO GTPases activate PKNs","1/51","24/2914",0.346528772197204,0.412946786868335,0.241151601704487,"AR",1
"R-HSA-5693579","R-HSA-5693579","Homologous DNA Pairing and Strand Exchange","1/51","24/2914",0.346528772197204,0.412946786868335,0.241151601704487,"BRCA1",1
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","1/51","24/2914",0.346528772197204,0.412946786868335,0.241151601704487,"JAK2",1
"R-HSA-9006335","R-HSA-9006335","Signaling by Erythropoietin","1/51","24/2914",0.346528772197204,0.412946786868335,0.241151601704487,"JAK2",1
"R-HSA-354192","R-HSA-354192","Integrin alphaIIb beta3 signaling","1/51","25/2914",0.358060617393724,0.424331505143391,0.247800020179431,"AKT1",1
"R-HSA-9006921","R-HSA-9006921","Integrin signaling","1/51","25/2914",0.358060617393724,0.424331505143391,0.247800020179431,"AKT1",1
"R-HSA-111996","R-HSA-111996","Ca-dependent events","1/51","26/2914",0.369392880638071,0.434163139160911,0.253541472507169,"MAPK1",1
"R-HSA-350054","R-HSA-350054","Notch-HLH transcription pathway","1/51","26/2914",0.369392880638071,0.434163139160911,0.253541472507169,"HDAC4",1
"R-HSA-912526","R-HSA-912526","Interleukin receptor SHC signaling","1/51","26/2914",0.369392880638071,0.434163139160911,0.253541472507169,"JAK2",1
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","1/51","27/2914",0.38052894818913,0.44240357391094,0.258353700382294,"JUN",1
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","1/51","27/2914",0.38052894818913,0.44240357391094,0.258353700382294,"JUN",1
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","1/51","27/2914",0.38052894818913,0.44240357391094,0.258353700382294,"TP53",1
"R-HSA-5693571","R-HSA-5693571","Nonhomologous End-Joining (NHEJ)","1/51","27/2914",0.38052894818913,0.44240357391094,0.258353700382294,"BRCA1",1
"R-HSA-3858494","R-HSA-3858494","Beta-catenin independent WNT signaling","2/51","76/2914",0.386297093221354,0.447895818897192,0.26156104747278,"CTNNB1/TCF7L2",2
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","1/51","28/2914",0.391472150004979,0.452672647849423,0.264350607749141,"SMAD4",1
"R-HSA-141424","R-HSA-141424","Amplification of signal from the kinetochores","1/51","29/2914",0.402225760659776,0.461376607815626,0.269433523886931,"PPP2CA",1
"R-HSA-141444","R-HSA-141444","Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal","1/51","29/2914",0.402225760659776,0.461376607815626,0.269433523886931,"PPP2CA",1
"R-HSA-381119","R-HSA-381119","Unfolded Protein Response (UPR)","1/51","29/2914",0.402225760659776,0.461376607815626,0.269433523886931,"CEBPB",1
"R-HSA-5696395","R-HSA-5696395","Formation of Incision Complex in GG-NER","1/51","30/2914",0.412793000246033,0.472235192281462,0.275774692094192,"UBE2I",1
"R-HSA-2151201","R-HSA-2151201","Transcriptional activation of mitochondrial biogenesis","1/51","32/2914",0.433380979487812,0.493157666313717,0.28799294462683,"GABPA",1
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","1/51","32/2914",0.433380979487812,0.493157666313717,0.28799294462683,"JAK2",1
"R-HSA-5685942","R-HSA-5685942","HDR through Homologous Recombination (HRR)","1/51","33/2914",0.443407894840387,0.499270306788783,0.291562588678028,"BRCA1",1
"R-HSA-72163","R-HSA-72163","mRNA Splicing - Major Pathway","1/51","33/2914",0.443407894840387,0.499270306788783,0.291562588678028,"ELAVL1",1
"R-HSA-72172","R-HSA-72172","mRNA Splicing","1/51","33/2914",0.443407894840387,0.499270306788783,0.291562588678028,"ELAVL1",1
"R-HSA-76009","R-HSA-76009","Platelet Aggregation (Plug Formation)","1/51","33/2914",0.443407894840387,0.499270306788783,0.291562588678028,"AKT1",1
"R-HSA-112040","R-HSA-112040","G-protein mediated events","1/51","34/2914",0.453260792224331,0.502451885954103,0.29342055908987,"MAPK1",1
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","1/51","34/2914",0.453260792224331,0.502451885954103,0.29342055908987,"MAPK1",1
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","1/51","34/2914",0.453260792224331,0.502451885954103,0.29342055908987,"MAPK3",1
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","1/51","34/2914",0.453260792224331,0.502451885954103,0.29342055908987,"CTNNB1",1
"R-HSA-2500257","R-HSA-2500257","Resolution of Sister Chromatid Cohesion","1/51","34/2914",0.453260792224331,0.502451885954103,0.29342055908987,"PPP2CA",1
"R-HSA-3214847","R-HSA-3214847","HATs acetylate histones","1/51","34/2914",0.453260792224331,0.502451885954103,0.29342055908987,"CLOCK",1
"R-HSA-983168","R-HSA-983168","Antigen processing: Ubiquitination & Proteasome degradation","2/51","88/2914",0.459765965921561,0.507934499445802,0.296622281604959,"KEAP1/FBXW7",2
"R-HSA-422475","R-HSA-422475","Axon guidance","5/51","254/2914",0.46198333745161,0.507934499445802,0.296622281604959,"ABL1/ERBB2/MAPK1/MAPK3/RPS6KA5",5
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","1/51","35/2914",0.462942632362025,0.507934499445802,0.296622281604959,"MAPK3",1
"R-HSA-446728","R-HSA-446728","Cell junction organization","1/51","35/2914",0.462942632362025,0.507934499445802,0.296622281604959,"CTNNB1",1
"R-HSA-199991","R-HSA-199991","Membrane Trafficking","3/51","144/2914",0.465820801695709,0.5097885814476,0.297705023640115,"AKT1/AKT2/AKT3",3
"R-HSA-212165","R-HSA-212165","Epigenetic regulation of gene expression","1/51","37/2914",0.481804737781762,0.525939522922077,0.307136808871192,"SIRT1",1
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","1/51","38/2914",0.490990680907633,0.533253169897151,0.311407813606973,"GABPA",1
"R-HSA-373755","R-HSA-373755","Semaphorin interactions","1/51","38/2914",0.490990680907633,0.533253169897151,0.311407813606973,"ERBB2",1
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","3/51","153/2914",0.506816731284762,0.549051458891826,0.320633657750594,"AKT1/MAPK1/MAPK3",3
"R-HSA-913531","R-HSA-913531","Interferon Signaling","2/51","97/2914",0.511559543024036,0.552793561605318,0.322818961261356,"JAK2/MAPK3",2
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","1/51","41/2914",0.517601152290545,0.556518532162014,0.324994259979289,"JAK2",1
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","1/51","41/2914",0.517601152290545,0.556518532162014,0.324994259979289,"JAK2",1
"R-HSA-418346","R-HSA-418346","Platelet homeostasis","1/51","42/2914",0.52616444544515,0.560110538699676,0.327091910711625,"PPP2CA",1
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","1/51","42/2914",0.52616444544515,0.560110538699676,0.327091910711625,"PTGS2",1
"R-HSA-69618","R-HSA-69618","Mitotic Spindle Checkpoint","1/51","42/2914",0.52616444544515,0.560110538699676,0.327091910711625,"PPP2CA",1
"R-HSA-72203","R-HSA-72203","Processing of Capped Intron-Containing Pre-mRNA","1/51","42/2914",0.52616444544515,0.560110538699676,0.327091910711625,"ELAVL1",1
"R-HSA-5653656","R-HSA-5653656","Vesicle-mediated transport","3/51","160/2914",0.537621165035404,0.570889801485615,0.333386756848427,"AKT1/AKT2/AKT3",3
"R-HSA-71387","R-HSA-71387","Metabolism of carbohydrates","1/51","44/2914",0.542846328971951,0.575015000318437,0.335795779844898,"PPP2CA",1
"R-HSA-512988","R-HSA-512988","Interleukin-3, Interleukin-5 and GM-CSF signaling","1/51","45/2914",0.550969965634819,0.582182549894919,0.339981466997892,"JAK2",1
"R-HSA-5696399","R-HSA-5696399","Global Genome Nucleotide Excision Repair (GG-NER)","1/51","46/2914",0.558952026196905,0.589165649234575,0.344059439376344,"UBE2I",1
"R-HSA-5663220","R-HSA-5663220","RHO GTPases Activate Formins","1/51","47/2914",0.56679492949675,0.594511062968474,0.347181040330013,"PPP2CA",1
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","1/51","47/2914",0.56679492949675,0.594511062968474,0.347181040330013,"JAK2",1
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","2/51","109/2914",0.57555112428442,0.60075774286622,0.350828960378261,"JAK2/CLOCK",2
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","2/51","109/2914",0.57555112428442,0.60075774286622,0.350828960378261,"JAK2/CLOCK",2
"R-HSA-983169","R-HSA-983169","Class I MHC mediated antigen processing & presentation","2/51","115/2914",0.605260619380823,0.630234965326148,0.368042992878477,"KEAP1/FBXW7",2
"R-HSA-163685","R-HSA-163685","Integration of energy metabolism","1/51","55/2914",0.624805693093505,0.647443580524429,0.378092435688416,"PPP2CA",1
"R-HSA-5696398","R-HSA-5696398","Nucleotide Excision Repair","1/51","55/2914",0.624805693093505,0.647443580524429,0.378092435688416,"UBE2I",1
"R-HSA-2467813","R-HSA-2467813","Separation of Sister Chromatids","1/51","56/2914",0.631498561107576,0.651232891142188,0.380305307549603,"PPP2CA",1
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","1/51","56/2914",0.631498561107576,0.651232891142188,0.380305307549603,"PPP2CA",1
"R-HSA-1500931","R-HSA-1500931","Cell-Cell communication","1/51","57/2914",0.638074339058421,0.656436190542117,0.383343916940311,"CTNNB1",1
"R-HSA-68882","R-HSA-68882","Mitotic Anaphase","1/51","60/2914",0.657119046281273,0.674411652762359,0.393841181100335,"PPP2CA",1
"R-HSA-2555396","R-HSA-2555396","Mitotic Metaphase and Anaphase","1/51","61/2914",0.663246211186548,0.679075476369998,0.396564748806428,"PPP2CA",1
"R-HSA-376176","R-HSA-376176","Signaling by ROBO receptors","1/51","64/2914",0.680990767936632,0.69558342724956,0.406205019470973,"ABL1",1
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","1/51","72/2914",0.723948775591656,0.735957404570664,0.429782510827673,"ERBB2",1
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","1/51","72/2914",0.723948775591656,0.735957404570664,0.429782510827673,"RPS6KA5",1
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","1/51","80/2914",0.761220270471581,0.772017721116568,0.450840921667877,"GABPA",1
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","2/51","165/2914",0.794851070760453,0.804224314519421,0.469648845186166,"MAPK1/MAPK3",2
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","6/51","436/2914",0.797026056989345,0.804527478702186,0.469825886225298,"AKT1/AKT2/AKT3/MAPK1/MAPK3/PPP2CA",6
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","6/51","486/2914",0.876217966274485,0.882388515332756,0.515294973988948,"AKT1/AKT2/AKT3/MAPK1/MAPK3/PPP2CA",6
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","1/51","125/2914",0.89521750206834,0.89922967429159,0.525129830649978,"MAPK1",1
"R-HSA-5663205","R-HSA-5663205","Infectious disease","1/51","126/2914",0.89713356782471,0.89922967429159,0.525129830649978,"CTNNB1",1
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","2/51","217/2914",0.903418016623386,0.903418016623386,0.527575728024453,"MAPK1/PPP2CA",2
